I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 27 studies | 28% ± 12% | |
| natural killer cell | 12 studies | 18% ± 5% | |
| capillary endothelial cell | 9 studies | 23% ± 10% | |
| CD16-positive, CD56-dim natural killer cell, human | 8 studies | 21% ± 7% | |
| endothelial cell of artery | 8 studies | 37% ± 19% | |
| fibroblast | 8 studies | 27% ± 12% | |
| CD16-negative, CD56-bright natural killer cell, human | 6 studies | 21% ± 4% | |
| endothelial cell of lymphatic vessel | 6 studies | 24% ± 4% | |
| pericyte | 5 studies | 31% ± 12% | |
| smooth muscle cell | 5 studies | 19% ± 3% | |
| cardiac muscle cell | 5 studies | 25% ± 4% | |
| endothelial cell of vascular tree | 5 studies | 22% ± 7% | |
| adipocyte | 4 studies | 31% ± 20% | |
| epithelial cell of proximal tubule | 3 studies | 18% ± 3% | |
| connective tissue cell | 3 studies | 47% ± 28% | |
| retina horizontal cell | 3 studies | 23% ± 6% | |
| ciliated cell | 3 studies | 19% ± 4% | |
| astrocyte | 3 studies | 28% ± 10% | |
| oligodendrocyte | 3 studies | 23% ± 3% |
